A 2022 report revealed that the US DOJ is in talks with Philips to negotiate the terms of a consent decree.
It could have dramatic consequences for Philips if it goes through, including:
Suspending production of all CPAP devices until the quality issues are resolved
Delaying the process of providing replacement devices to affected customers